CSF Therapeutics

CSF Therapeutics is a biotechnology company focused on developing novel treatments for central nervous system (CNS) disorders by targeting the choroid plexus and the cerebrospinal fluid (CSF) system. The company leverages insights into the choroid plexus's role as a 'gatekeeper' and 'factory' for the brain to regulate CSF production and composition. Their primary focus includes treating hydrocephalus and other conditions where CSF dynamics are impaired, offering a potential non-surgical alternative to traditional shunting procedures. By modulating the choroid plexus, CSF Therapeutics aims to restore brain homeostasis and deliver therapeutic agents directly to the CNS. The company's platform utilizes both gene therapy and small molecule approaches to address unmet needs in neurology and neurodegeneration.